Regional Reach CBS Labs serves clients across the US and Caribbean, signaling strong cross-border demand and opportunities for regional partnerships, joint ventures, and logistics-enabled testing programs with clinics, private practices, and universities.

Broad Diagnostic Capabilities With PCR, qPCR, RT-PCR, Next Generation Sequencing and DNA microarrays, the lab can support clinical trials, diagnostic panels, toxicology testing, and research projects, enabling bundled service offerings for pharma, CROs, and academic partners.

Diverse Client Base A mix of private practices, public and private clinics, research universities, and Bio/Pharma clients provides multiple paths to recurring revenue through long-term service agreements and volume-based pricing.

Growth Potential A revenue range of 1M to 10M signals a mid-market footprint with opportunities to scale through larger projects, managed services, and ongoing testing programs with regional institutions.

Genomics Growth Engine Advanced sequencing and molecular platforms position CBS Labs to explore genomics driven services, including pharmacogenomics or companion diagnostics collaborations, as demand for precision medicine grows.